The assessment and management of head injury algorithm is amended in line with this recent JRCALC update: ‘Following the results of the CRASH 3 trial, Tranexamic Acid should be administered to any patient aged 18 years and over who has a known or suspected head injury, with a GCS of 12 or less, where the injury has occurred within the last 3 hours.’
Description:
Date Update Posted Online: July 17, 2020